Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 15 January 2026

Pfizer stock dips as U.S. vaccine policy fight rattles demand outlook

Pfizer stock dips as U.S. vaccine policy fight rattles demand outlook

New York, Jan 15, 2026, 11:16 EST — Regular session. Pfizer Inc. shares fell 0.6% to $25.42 in late-morning trading on Thursday, extending a choppy start to the year for the drugmaker’s stock. The stock has struggled to find a clear driver since Pfizer warned in December that 2026 would likely start “bumpy,” with lower COVID-related sales, price cuts tied to a U.S. government deal and key patent expirations looming. Loss of exclusivity is shorthand for patents ending, which can open the door to cheaper rivals. (Reuters) The political noise around vaccines is back in focus. Sanofi Chief Executive Paul
15 January 2026
·········
Capital One stock rises as traders weigh US credit-card rate cap risk ahead of earnings

Capital One stock rises as traders weigh US credit-card rate cap risk ahead of earnings

New York, Jan 15, 2026, 12:31 PM ET — Trading in the regular session. Shares of Capital One Financial Corp climbed Thursday, building on a recovery after earlier declines as investors reconsidered the policy risks tied to U.S. credit-card pricing. The stock gained 2.2%, reaching $239.55 by midday trading. The lender is at the heart of the debate about whether Washington can — or will — push down credit-card interest rates. For shareholders, the implications are clear: lower rates could slash interest income, prompting lenders to tighten credit, cut rewards, or hike fees. That debate is running headlong into earnings
15 January 2026
····
Adobe stock slips again as Oppenheimer downgrade and Apple’s Creator Studio keep pressure on ADBE

Adobe stock slips again as Oppenheimer downgrade and Apple’s Creator Studio keep pressure on ADBE

New York, January 15, 2026, 12:42 EST — Regular session Adobe Inc shares edged down 0.6% to $302.49 on Thursday midday, even as the Invesco QQQ Trust tracking the Nasdaq 100 rose about 1%. Salesforce slid more than 3%, while the S&P 500 ETF SPY added about 0.6%. The slide comes two days after Oppenheimer cut Adobe to “Perform” from “Outperform,” warning that generative AI — tools that can create images and video from text prompts — is tightening competition from OpenAI, Meta and others. “Gen AI is increasing the velocity of content creation while lowering price and subscriber growth,”
15 January 2026
······
Accenture stock steadies near $289 as Wells Fargo raises target; traders eye March 19 earnings call

Accenture stock steadies near $289 as Wells Fargo raises target; traders eye March 19 earnings call

New York, Jan 15, 2026, 12:24 EST — Regular session Accenture plc shares (ACN) were up about 0.1% at $288.87 on Thursday, holding most of Wednesday’s 4.2% jump. The stock closed the prior session at $288.54. (MarketWatch) The move matters because investors are trying to pin down whether corporate tech budgets are finally thawing, after a year of stop-start spending on big projects. For Accenture, bookings and discretionary work are the tell, not the chatter. Analyst notes are landing in a market that wants evidence, fast. Any hint that CIOs are reopening wallets can move the group, even if the
15 January 2026
·····
AST SpaceMobile stock flirts with $100 as Zacks’ “Bear of the Day” clashes with satellite bulls

AST SpaceMobile stock flirts with $100 as Zacks’ “Bear of the Day” clashes with satellite bulls

New York, Jan 15, 2026, 11:56 EST Shares of AST SpaceMobile climbed roughly 4% Thursday, hovering near $99 amid sharply divided opinions on the satellite-to-smartphone firm’s valuation and execution risks. The tug-of-war is crucial now as “direct-to-device” connectivity—satellites linking regular smartphones without cell towers—shifts from demos to early commercial rollout. This shift has pushed what was once a niche telecom gamble into the spotlight for retail investors and telecom executives alike. AST plans to roll out 45 to 60 satellites in 2026, a milestone its supporters believe could transform coverage in rural and remote regions. Skeptics, however, warn this ambitious
15 January 2026
·····
Home Depot stock nudges higher after Morgan Stanley lifts target as housing signals loom

Home Depot stock nudges higher after Morgan Stanley lifts target as housing signals loom

New York, Jan 15, 2026, 12:21 EST — Regular session underway. Shares of Home Depot (HD) ticked up 0.5% to $377.75 midday Thursday after Morgan Stanley boosted its price target for the home-improvement giant. The firm raised its 12-month target to $412 from $395, maintaining an “Overweight” rating, indicating it expects HD to outperform its peers. Meanwhile, Lowe’s shares crept up 0.4%, and Sherwin-Williams saw little movement. (TipRanks) This move is significant since Home Depot stands at the crossroads of housing trends, interest rates, and consumer sentiment. Investors have been eager to see if homeowners will kick off larger, financed
15 January 2026
·····
Kenvue stock is up today — here’s what the Kimberly-Clark deal is worth now

Kenvue stock is up today — here’s what the Kimberly-Clark deal is worth now

New York, January 15, 2026, 11:16 EST — Regular session. Kenvue Inc shares rose about 0.5% to $17.21 on Thursday, as Kimberly-Clark — the would-be buyer — gained roughly 0.7% to $99.81, lifting the implied value of the takeover offer. The broader market was firmer, with the S&P 500’s main ETF up about 0.6%, while the consumer staples ETF was little changed. This matters now because KVUE has been trading like a deal stock. The cash part is fixed, but the stock part moves every time Kimberly-Clark moves. It leaves investors focused on the “spread” — the gap between Kenvue’s
15 January 2026
·····
AbbVie stock slides 2% as obesity push takes center stage at JPM conference

AbbVie stock slides 2% as obesity push takes center stage at JPM conference

New York, January 15, 2026, 12:11 (EST) — Regular session AbbVie shares dropped 2.1% to $217.13 Thursday following the company’s expanded plans for obesity treatments announced at the J.P. Morgan Healthcare Conference. This matters since AbbVie is hunting for its next major growth driver, as its aging blockbuster Humira grapples with increased competition from biosimilars. Investors have shown they’re eager to back solid obesity treatments—and just as ready to slam unclear prospects. Obesity drugs are turning into a fresh battleground for big pharma. Novo Nordisk and Eli Lilly currently lead the pack, but future victors may hinge on side effects,
15 January 2026
···
Intuitive Surgical stock slips again as 2026 da Vinci outlook keeps pressure on ISRG

Intuitive Surgical stock slips again as 2026 da Vinci outlook keeps pressure on ISRG

New York, January 15, 2026, 12:06 (EST) — Regular session Intuitive Surgical shares dropped once more on Thursday, continuing a selloff sparked by the company’s weaker growth forecast for procedures involving its da Vinci surgical robot. The stock slipped roughly 1% to $541.08 in midday trading, following a 2.7% drop on Wednesday. The procedure forecast is crucial because every da Vinci surgery drives repeat sales — the single-use instruments and accessories hospitals need for each operation. If that volume dips, the growth story shrinks, even if robot deliveries remain steady. Investors are weighing how quickly Intuitive can roll out its
15 January 2026
·····
UnitedHealth stock rebounds as rural Medicare payment pilot rolls out, earnings next in focus

UnitedHealth stock rebounds as rural Medicare payment pilot rolls out, earnings next in focus

New York, January 15, 2026, 12:01 EST — Regular session UnitedHealth Group Incorporated shares rebounded from an early dip, climbing roughly 0.7% to $337.27 by late morning Thursday. The stock had fallen to an intraday low of $328.14 before bouncing back. The rebound came after UnitedHealthcare announced it is trialing quicker payment schedules for rural hospitals— a modest shift, but one that hits a sensitive nerve in the business. Medicare Advantage, the privately managed alternative to traditional Medicare, has long been a major profit driver for big insurers. Now, it’s also under the microscope politically and regulatorily, as the government
15 January 2026
···
Boeing stock rises on Bernstein target hike as Delta’s Dreamliner deal keeps focus on deliveries

Boeing stock rises on Bernstein target hike as Delta’s Dreamliner deal keeps focus on deliveries

NEW YORK, Jan 15, 2026, 12:16 EST — Trading in the regular session. Boeing (BA) shares climbed 1.6% to $246.40 by midday Thursday following a price target boost from Bernstein. Analyst Douglas S. Harned maintained a Buy rating and raised the target to $298 from $277, according to MarketScreener data. (MarketScreener) The stock hinges on a straightforward issue: whether Boeing can boost production and convert its growing backlog into reliable cash flow—without facing another production hiccup or safety problem. Deliveries are the key driver of both the numbers and sentiment, since the manufacturer records most of its revenue at that
15 January 2026
······
Petrobras stock (PBR) slips as oil falls; Tupi hits 1 million bpd, fertilizer restart in focus

Petrobras stock (PBR) slips as oil falls; Tupi hits 1 million bpd, fertilizer restart in focus

Rio de Janeiro, Jan 15, 2026, 12:45 BRT — Regular session Petrobras’ shares listed in the U.S. slipped Thursday, despite the Brazilian oil giant highlighting new operational progress at its key offshore fields. Petróleo Brasileiro S.A. – Petrobras is heavily dependent on volume. Production from the pre-salt—deepwater reserves buried beneath a thick salt layer—has powered earnings and dividends lately, and traders react swiftly to any sign that this growth is slowing. Petrobras is also pressing forward with another venture: fertilizers. The timeline for reviving its urea and ammonia plants in Brazil’s northeast has turned into a subtle yet telling sign
15 January 2026
····
1 … 528 529 530 531 532 … 1,916

Stock Market Today

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

7 February 2026
CapitaLand Investment shares rose 1.3% to S$3.12 on Friday, bucking a 0.8% drop in Singapore’s benchmark index. CapitaLand Integrated Commercial Trust reported a 16.4% jump in second-half distributable income, while CapitaLand Ascendas REIT posted a 1.4% full-year rise. CapitaLand China Trust saw full-year DPU fall to 4.82 cents amid weaker yuan and occupancy. CLI reports FY2025 results on Feb. 11.
Keppel stock holds near 12-year high after profit jump, special dividend; buyback adds support

Keppel stock holds near 12-year high after profit jump, special dividend; buyback adds support

7 February 2026
Keppel shares closed at S$11.64 on Friday, up 0.17%, after surging 6.1% the previous day on stronger FY2025 profit and a larger dividend plan. The company bought back 151,400 shares for about S$1.74 million. Keppel reported a 29% rise in full-year profit to S$1.02 billion and proposed a total distribution of 47 cents per share, including a special dividend partly paid in Keppel REIT units.
Go toTop